Christopher Lucasti DO

Physician

730 Shore RdSomers Point, NJ 08244
Phone+1 609-927-6662
Fax+1 609-927-2942

Dr. Lucasti is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Lucasti's full profile Already have an account?

Education & Training

Philadelphia College of Osteopathic MedicineClass of 1986

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

NJ State License 1988 - 2027
PA State License 1987 - 2020
AOA Board of Internal Medicine Infectious Disease

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification Allscripts MyWay EHR, Allscripts, 2013, 2015-2017
CMS Meaningful Use Stage 2 Certification Aprima PRM 2015, Aprima Medical Software, Inc., 2013, 2015-2017

Clinical Trials

Long-term Observational Study in HIV Subjects Exposed to EGRIFTA®
TERMINATED
Study of Debio 1450 for Bacterial Skin Infections
COMPLETED
PHASE2
A Clinical Trial of STP0404 in Adults With HIV-1 Infection Start of enrollment: 2023 May 23
COMPLETED
PHASE2
Roles: Contact

Publications & Presentations

PubMed

Safety and Immunogenicity of BNT162b2 in Antiretroviral Therapy-Treated People With HIV.
Essack Mitha, Mezgebe Berhe, Judith Aberg, Christopher J Lucasti, Fadi Chalhoub
Open Forum Infectious Diseases. 2026-07-01
Combined Use of Ibalizumab and Lenacapavir for the Treatment of Multidrug-resistant HIV-1: A Case Series.
Charlotte Rolle, Amit Achhra, Christina Harbison, Diana Finkel, Christopher Lucasti
Clinical Infectious Diseases. 2026-03-17
Fc-Modified Antibody in Hospitalized Severe COVID-19 Patients.
Felipe Dal-Pizzol, Suzana Margareth Lobo, Christopher Lucasti, Adam Abdul Hakeem Baidoo, Huo Su
Vaccines. 2025-03-31